CZCui Zhao

Cui Zhao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Cui Zhao has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Family trio-based sequencing in 404 sporadic bilateral hearing loss patients discovers recessive and De novo genetic variants in multiple ways

    by Jing Guan, Jin Li, Guohui Chen, Tao Shi, Lan Lan, Xiaonan Wu, Cui Zhao, Dayong Wang, Hongyang Wang, Qiuju Wang


  • Temperature sensitive auditory neuropathy

    by Qiujing Zhang, Lan Lan, Wei Shi, Lan Yu, Lin-Yi Xie, Fen Xiong, Cui Zhao, Na Li, Zifang Yin, Liang Zong, et al.


    • 1 April 2010
      • Vol. 26  (4) , 376-8

    [Analyzing GRIA3 gene mutations located in AUNX1 locus in a Chinese pedigree with auditory neuropathy].

    by Qiong Liu, Dong-Yi Han, Yu-Bin Ji, Jian-Qiang Li, Lan Lan, Cui Zhao, Qiu-Ju Wang

    To analyze the mutations of AQP3 gene for the purpose of identifying the causative gene located in DFNA55 locus in a Chinese pedigree with autosomal dominant nonsyndromic deafness (DeaFNess Autosomal, DFNA). There were 21 DNA sample in this pedigree, among whom 9 were patients and 12 had normal hearing. The coding sequences of AQP3 gene were amplified by polymerase chain reaction (PCR) with 5 pairs of primers, and PCR product s bidirectional sequencing were performed and analyzed with DNA Star Software. Two point mutations were detected. The first mutant point was 390C>T/390C>T(F130F) nexon 4 all members in pedigree. The second mutant point was 394G>A/WT(D132N), which were found in 3 patients and 1 member with normal hearing. We found two point mutations that one caused no amino acid changed and the other caused D132N, but AQP3 gene isn't the responsible gene for this pedigree with auditory neuropathy.


    • 29 September 2009
      • Vol. 89  (36) , 2531-5

    [Evaluation of deaf-mute patients with sensitive deafness gene screening in Shandong province].

    by Yu-Bin Ji, Dong-Yi Han, Da-Yong Wang, Yu Zhou, Cui Zhao, Hui Wang, Lan Lan, Qiu-Ju Wang

    To discuss how to determine the number of samples in epidemiological study about deafness genes and reveal the characteristics of GJB2, SLC26A4 and mitochondrial DNA A1555G mutations in deaf-mute patients in schools for deaf-mutes in Shandong Province. A total of 485 subjects were collected from the different schools for deaf-mutes in Shandong province. Amplified target fragments included GJB2 coding sequence, mtDNA12SrRNA and exon 8, 10, 17, 19 of SLC26A4 gene. The amplicons of mtDNA 12S rRNA were subjected to restriction enzyme Alw26I. The amplicons of patients whose enzyme reaction highly indicating A1555G mutation, amplicons of GJB2 and those exons PCR products of SLC26A4 were directly sequenced. The study revealed that 36.29% patients had two mutated alleles (homozygote & compound heterozygote) of GJB2 (24.12%) and SLC26A4 (6.60%) and mtDNA12SrRNA A1555G (5.57%). The 235delC and IVS7-2A > G were still the mutational hot spot in GJB2 and SLC26A4 respectively. The method of determining the number of sample is very important in the epidemiological study. There were about 24 thousand deaf-mute patients who were caused by three sensitive deafness genes mutations in Shandong province. Screening the sensitive deafness genes in newborn is imminent.


    • 1 March 2009
      • Vol. 44  (3) , 177-81

    [Audiological and genetic studies on 130 infants with hearing loss].

    by Da-Yong Wang, Qiu-Ju Wang, Lan Lan, Wei Shi, Cui Zhao, Pei-Lin Hui, Shaoqi Rao, Dong-Yi Han

    To investigate the genetic etiologies in the 0- 3-years-old infants with hearing loss and to analyze the interaction between genetics and environmental factors. Total of 130 infants were performed detailed audiological evaluation as well as the detection of the popular deafness gene mutations in GJB2 gene, SLC26A4 and mtDNA12SrRNA. Of them, 84 cases were performed the computer tomography or magnetic resonance imaging examinations. Of the 130 cases, 54 infants were diagnosed as large vestibular aqueduct syndrome, while seven of 130 were as auditory neuropathy and the others were diagnosed as sensorineural hearing loss. Considering of the risks of etiologies for hearing loss, 85 of them had the experiences of the high risk factors at birth (65.4%, 85/130), while 23 of them had the exposure of aminoglycoside antibiotics, and 13 had the family history background as well as two cases were from the consanguineous families. In the causative genes screening, 42 infants were caused by the mutations of SLC26A4 gene (32.3%), but 14 infants found the mutations in GJB2 gene (4.6%), and no infants carried the mutation in mtDNA 12SrRNA 1555G and 1494T points in our studies. In our studies, about 36.9% infants hearing loss cases can be found the mutations in SLC26A4 and GJB2 genes. It is essential to put the idea into the hearing evaluation combined with genetic testing for the diagnoses of hearing loss. It is also helpful for exploring the etiologies of hearing loss and performing the target genetic consulting for decreasing the prevalence of deafness in the future.

    • 1 November 2007
      • Vol. 42  (11) , 809-13

    [Studies of the strategy for newborn gene screening].

    by Qiu-Ju Wang, Ya-Li Zhao, Lan Lan, Cui Zhao, Ming-Kun Han, Dong-Yi Han

    To discuss and analyze the feasibility and strategy for perform the newborn gene screening in the process of newborn hearing screening in order to supply the defects or limitation in the hearing screening. Four hundreds and sixty newborn babies from December 2006 to April 2007 accepted the simultaneous hearing and gene screening. Otoacoustic emission (OAE) was used for the first step hearing screening and OAE combined with auto auditory brainstem response (AABR) detection for the second step screening. Newborn genetic disease screening cards were used for collecting the blood spot from the umbilical cord within the moment of newborn. The cards could be directly performed the polymerase chain reaction (PCR) for screening the mitochondrial 12SrRNA 1555G and GJB2 as well as SLC26A4 genes mutations. The restriction enzyme Alw26I was used to recognize the point mutation of 12SrRNA A1555G. The samples with the possible 12SrRNA A1555G mutation were then sequenced to verify. The PCR products from the GJB2 coding region and SLC26A4 IVS7-2A > G hot spot region were sequenced directly. The software of DNAStar was used to analysis the sequence. The first step of hearing screening of 460 newborn babies showed " refer" on the left ear of nine babies and on the right ear of three babies. Seven showed "refer" on bilateral with the the total of babies 19. After 42 days, they accepted the second step for hearing screening. 16 of the 19 were showed "pass" with OAE and AABR. One baby showed "pass" on the left ear, "refer" on the right ear with the OAE detection but bilateral "pass" with AABR. Two babies failed to accept the re-examination. The newborn gene screening showed five of the 460 babies had the positive response on the A1555G restriction enzyme assay. Of the five babies, one was proved to be the 12SrRNA A1555G mutation and three were the C1556T mutations and one sequence was normal. For the SLC26A4 gene screening, five were the heterozygote of IVS7-2A > G mutation were found and one was carrier the polymorphism of IVS7-18T > G and another was IVS6-62_63insGT heterozygote carrier. For the GJB2 gene screening, eight were 235delC heterozygote carriers, four were G109A heterozygote carriers. All the gene screening found 23 newborn babies of the 460 harbored the changes in the three genes. Of those, one was the 12SrRNA A1555G. pathogenic mutation and 13 were pathogenic heterozygote carriers, nine were the polymorphisms. It was worth to pay more attentions that A1555G mutation was found in the baby whose hearing screening was "pass" in the hearing screening as well as the 13 heterozygote carrier for GJB2 and SLC26A4 gene. It might be one of the powerful strategy for adding the concept of newborn gene screening into the hearing screening for the purpose of early diagnosis and discovery the prelingual or late-onset or the high risk as well as the pathogenic carriers. On the basis of the research progress, it was necessary to develop the national newborn gene screening into the process of newborn hearing screening.


    • 1 October 2007
      • Vol. 42  (10) , 739-42

    [Mitochondrial DNA A1555G mutation analysis in 802 nonsyndromic hearing impairment patients].

    by Xiao-Wen Liu, Yu-Fen Guo, Dong-Yi Han, Ya-Li Zhao, Lan Lan, Cui Zhao, Qiu-Ju Wang

    To investigate the prevalence of the mitochondrial DNA (mtDNA) A1555G mutation in nonsyndromic hearing impairment (NSHI) patients from Gansu province. Subjects included 802 students selected from five Deaf-Mute Schools in Gansu. DNA was extracted from peripheral blood of all patients. The mitochondrial DNA target fragments were amplified by polymerase chain reaction (PCR). The Mutations were detected by AIw26I digestion and sequence analysis. The homoplasmic A1555G mutation was found in 67 individuals from 802 patients (8.4%). Fifteen of these 67 patients had family histories. The mtDNA A1555G mutation had a higher incidence in Gansu population with nonsyndromic hearing impairment than other studies. The data not only gaven more evidences that the prevalence of mtDNA A1555G mutation in china was higher than that in Europe and America, but also gaven valuable information for gene diagnosis, genetic counseling and would improve the safety of aminoglycoside antibiotic therapy.